Abcellera Biologics Inc (ABCL) earnings · rev $12.4M
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
This ABCL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
When the next ABCL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 48.7% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ABCL research stays on the stock page; the tape stays on the quote page.
Not investment advice.